NEURONTIN

Generic: GABAPENTIN

Manufacturer: Parke-Davis Div Of Pfizer Inc

Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]Loop Diuretic [EPC]
348,056
Total Reports
115,104
Serious Reports
32,951
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.47%)

Patient Demographics

Male
112,865
Female
209,061

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for NEURONTIN.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 28,732
7.5%
2 FATIGUE 24,149
6.3%
3 NAUSEA 21,801
5.7%
4 PAIN 20,604
5.4%
5 OFF LABEL USE 18,756
4.9%
6 DIARRHOEA 17,363
4.5%
7 HEADACHE 17,174
4.5%
8 DIZZINESS 15,653
4.1%
9 FALL 15,081
3.9%
10 DYSPNOEA 13,669
3.6%
11 VOMITING 11,637
3.0%
12 ASTHENIA 11,580
3.0%
13 PAIN IN EXTREMITY 11,303
3.0%
14 ARTHRALGIA 11,113
2.9%
15 DEATH 10,658
2.8%
16 MALAISE 10,434
2.7%
17 PNEUMONIA 10,025
2.6%
18 DRUG HYPERSENSITIVITY 9,980
2.6%
19 DEPRESSION 9,910
2.6%
20 ANXIETY 9,767
2.5%
21 INSOMNIA 9,267
2.4%
22 SOMNOLENCE 9,262
2.4%
23 BACK PAIN 8,969
2.3%
24 RASH 8,615
2.2%
25 WEIGHT DECREASED 8,403
2.2%
26 FEELING ABNORMAL 8,212
2.1%
27 CONDITION AGGRAVATED 8,033
2.1%
28 GAIT DISTURBANCE 7,951
2.1%
29 CONSTIPATION 7,662
2.0%
30 PRURITUS 7,362
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.